BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29530488)

  • 21. Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.
    Liu J; Xu H; Qing H; Li Y; Yang X; He C; Ren J; Zhou P
    Front Oncol; 2020; 10():634298. PubMed ID: 33604303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
    Sundaram V; Gould MK; Nair VS
    Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.
    Kim HY; Jung KW; Lim KY; Lee SH; Jun JK; Kim J; Hwangbo B; Lee JS
    Cancer Res Treat; 2018 Jul; 50(3):748-756. PubMed ID: 28724283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
    Crucitti P; Gallo IF; Santoro G; Mangiameli G
    Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Study of the Prediction of Malignancy in Thyroid Nodules: Modified Score versus 2017 American College of Radiology's Thyroid Imaging Reporting and Data System Ultrasound Lexicon.
    Jin ZQ; Yu HZ; Mo CJ; Su RQ
    Ultrasound Med Biol; 2019 Jul; 45(7):1627-1637. PubMed ID: 31064698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
    Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
    Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Lung-RADS in different target populations: a systematic review and meta-analysis.
    Mao Y; Cai J; Heuvelmans MA; Vliegenthart R; Groen HJM; Oudkerk M; Vonder M; Dorrius MD; de Bock GH
    Eur Radiol; 2024 Mar; 34(3):1877-1892. PubMed ID: 37646809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
    van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer.
    Lin KF; Wu HF; Huang WC; Tang PL; Wu MT; Wu FZ
    BMC Pulm Med; 2017 Sep; 17(1):120. PubMed ID: 28874145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
    Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
    AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
    Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
    Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study to evaluate CT-based semantic and radiomic features in preoperative diagnosis of invasive pulmonary adenocarcinomas manifesting as subsolid nodules.
    Wu YJ; Liu YC; Liao CY; Tang EK; Wu FZ
    Sci Rep; 2021 Jan; 11(1):66. PubMed ID: 33462251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
    Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
    Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung Cancer CT Screening and Lung-RADS in a Tuberculosis-endemic Country: The Korean Lung Cancer Screening Project (K-LUCAS).
    Kim H; Kim HY; Goo JM; Kim Y
    Radiology; 2020 Jul; 296(1):181-188. PubMed ID: 32286195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Efficiency and Adherence in Asian Lung Cancer Screening: Comparing Self-paid and Clinical Study Approaches in Taiwan.
    Wu YJ; Tang EK; Wu FZ
    Acad Radiol; 2024 May; 31(5):2109-2117. PubMed ID: 38480076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.
    Rzyman W; Jelitto-Gorska M; Dziedzic R; Biadacz I; Ksiazek J; Chwirot P; Marjanski T
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):969-73. PubMed ID: 24008181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.